Citigroup’s UROPLASTY INC-NEW UPI Stock Holding History

Citigroup’s Portfolio UPI Stock Details UPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-312	Closed	–	–	8121
2015 Q1	$0	Buy	312 +112	+56%	+$151	﹤0.01%	7716
2014 Q4	$0	Sell	200 -100	-33%	-$237	﹤0.01%	7562
2014 Q3	$1K	Buy	300 +100	+50%	+$261	﹤0.01%	7012
2014 Q2	$1K	Hold	200	–	–	﹤0.01%	7059
2014 Q1	$1K	Sell	200 -100	-33%	-$391	﹤0.01%	6940
2013 Q4	$1K	Buy	300 +100	+50%	+$305	﹤0.01%	6927
2013 Q3	$1K	Sell	200 -1,481	-88%	-$4.14K	﹤0.01%	6748
2013 Q2	$3K	Buy	+1,681	New	+$3.85K	﹤0.01%	6488

Citigroup's UPI Position: Q2 2015 in Review

Citigroup sold out of UROPLASTY INC-NEW (UPI) in Q2 2015, closing a stake of 312 shares.

Citigroup first reported a position in UPI in Q2 2013 and held it in 8 quarters. The position peaked at $3K in Q2 2013. 0 funds tracked by Wall St. Rank hold UPI as of Q2 2015.

Citigroup reported no remaining UROPLASTY INC-NEW position as of Q2 2015 after selling out during the quarter.
Citigroup sold 312 UROPLASTY INC-NEW shares in Q2 2015.
Citigroup first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 8 quarters.
Citigroup's UROPLASTY INC-NEW position peaked at $3K in Q2 2013.
0 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.